Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 551.00
+20.70 (3.90%)
At close: Feb 20, 2026
109.90% (1Y)
| Market Cap | 1.37B +138.0% |
| Revenue (ttm) | 35.81M +24.1% |
| Net Income | -224.02M |
| EPS | -0.97 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,028 |
| Average Volume | 12,557 |
| Open | 530.30 |
| Previous Close | 530.30 |
| Day's Range | 530.30 - 555.00 |
| 52-Week Range | 136.90 - 666.00 |
| Beta | 1.80 |
| RSI | 55.86 |
| Earnings Date | Mar 12, 2026 |